Page 29 - P4403.14_V91_YOUROTC_Book APRIL_2024_PRINT

HEALTHCARE 29

MAX STRENGTH

MAX STRENGTH

PARACETAMOL

PARACETAMOL *

IN ONE EFFERVESCENT TABLET

IN ONE EFFERVESCENT TABLET *

GETS TO WORK
UP TO
2X
GETS TO WORK
UP TO
FASTER
2X
THAN REGULAR PARACETAMOL TABLETS**
FASTER

THAN REGULAR PARACETAMOL TABLETS**

Save

Up Off
To 9%
Trade

From the makers of Solpadeine ®

From the makers of Solpadeine ®
EXCLUSIVE TO
PHARMACY

EXCLUSIVE TO Product Size Buying RRP Trade POR Pip Code
Offer
Price/
%
PHARMACY Single %
SOLPAONE
New brand *1 tablet = 1 dose (take only one tablet at a time) **Based on absorption data
†
£3.06
SolpaOne Soluble tablets 12s
SolpaOne 1000mg Effervescent Tablets (P) contain paracetamol. For short term symptomatic treatment of mild to moderate pain and/or fever. For adults 419-3819
29%
£5.19
9%
®
and adolescents over 50kg of body weight aged 16 years and above. 1 tablet = 1 dose (take only one tablet at a time). Do not take more than 4 tablets (4000mg)
per day. Do not use for more than 3 days unless on medical advice. Maximum paracetamol strength in 1 tablet. MAH: Cipla (EU) Limited Dixcart House,
Addlestone Road, Bourne Business Park, Addlestone, Surrey, KT15 2LE, UK. Information about this product, including adverse reactions, precautions, contra-
†
New brand *1 tablet = 1 dose (take only one tablet at a time) **Based on absorption data
indications, and method of use can be found at: https://mhraproducts4853.blob.core.windows.net/docs/f433587536fc4ebbcbb10e2c53c96c280676733d.
®
SolpaOne 1000mg Effervescent Tablets (P) contain paracetamol. For short term symptomatic treatment of mild to moderate pain and/or fever. For adults
and adolescents over 50kg of body weight aged 16 years and above. 1 tablet = 1 dose (take only one tablet at a time). Do not take more than 4 tablets (4000mg)
per day. Do not use for more than 3 days unless on medical advice. Maximum paracetamol strength in 1 tablet. MAH: Cipla (EU) Limited Dixcart House, UK/2023-255
Addlestone Road, Bourne Business Park, Addlestone, Surrey, KT15 2LE, UK. Information about this product, including adverse reactions, precautions, contra-
indications, and method of use can be found at: https://mhraproducts4853.blob.core.windows.net/docs/f433587536fc4ebbcbb10e2c53c96c280676733d.
UK/2023-255